The Treatment of Nonmetastatic High Grade Osteosarcoma of the Extremity: Review of the Italian Rizzoli Experience. Impact on the Future View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2009-08-12

AUTHORS

Stefano Ferrari , Emanuela Palmerini , Eric L. Staals , Mario Mercuri , Bertoni Franco , Piero Picci , Gaetano Bacci

ABSTRACT

The Bone Tumor Center of the “Istituto Ortopedico Rizzoli” was established in 1955 with the aim of studying and treating the musculoskeletal tumors. Between 1959 and 2006, 1245 patients with high grade nonmetastatic osteosarcoma of the extremity were treated at our Institute. Most of them were enrolled in study protocols.In the “prechemotherapy era”, the cure rate was 11%, with an amputation rate of 90%. Our first experience with adjuvant chemotherapy was in 1972. A total of 223 patients received adjuvant chemotherapy, with a disease-free survival (DFS) ranging from 45% to 53%, according to the chemotherapy protocol used. With the introduction of neoadjuvant chemotherapy, the resection rate increased and reached 94%, when high dose fosfamide was added to standard doses of methotrexate, cisplatin, and adriamycin.In the last few years, the results of treatment of nonmetastatic osteosarcoma of the extremity have reached a plateau (64% five-year DFS), and strategies of dose intensification are not able to improve the prognosis. Not only new active drugs, but also different approaches to the disease, are needed.In this regard, we are now investigating tumor microenvironment-targeted agents and chemotherapy protocols based on prospective biological stratification of patients.Collaborative projects with international groups and institutions are crucial for this rare disease. More... »

PAGES

275-287

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14

DOI

http://dx.doi.org/10.1007/978-1-4419-0284-9_14

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009972078

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20213396


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Extremities", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteosarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Sezione di Chemioterapia, dei Tumori dell\u2019 Apparato Locomotore, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419038.7", 
          "name": [
            "Sezione di Chemioterapia, dei Tumori dell\u2019 Apparato Locomotore, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrari", 
        "givenName": "Stefano", 
        "id": "sg:person.013005321532.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Palmerini", 
        "givenName": "Emanuela", 
        "id": "sg:person.01210215667.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Staals", 
        "givenName": "Eric L.", 
        "id": "sg:person.01324444267.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324444267.96"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Mercuri", 
        "givenName": "Mario", 
        "id": "sg:person.01062073475.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062073475.32"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Franco", 
        "givenName": "Bertoni", 
        "type": "Person"
      }, 
      {
        "familyName": "Picci", 
        "givenName": "Piero", 
        "id": "sg:person.0753274552.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Bacci", 
        "givenName": "Gaetano", 
        "id": "sg:person.01275050611.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275050611.54"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2009-08-12", 
    "datePublishedReg": "2009-08-12", 
    "description": "The Bone Tumor Center of the \u201cIstituto Ortopedico Rizzoli\u201d was established in 1955 with the aim of studying and treating the musculoskeletal tumors. Between 1959 and 2006, 1245 patients with high grade nonmetastatic osteosarcoma of the extremity were treated at our Institute. Most of them were enrolled in study protocols.In the \u201cprechemotherapy era\u201d, the cure rate was 11%, with an amputation rate of 90%. Our first experience with adjuvant chemotherapy was in 1972. A total of 223 patients received adjuvant chemotherapy, with a disease-free survival (DFS) ranging from 45% to 53%, according to the chemotherapy protocol used. With the introduction of neoadjuvant chemotherapy, the resection rate increased and reached 94%, when high dose fosfamide was added to standard doses of methotrexate, cisplatin, and adriamycin.In the last few years, the results of treatment of nonmetastatic osteosarcoma of the extremity have reached a plateau (64% five-year DFS), and strategies of dose intensification are not able to improve the prognosis. Not only new active drugs, but also different approaches to the disease, are needed.In this regard, we are now investigating tumor microenvironment-targeted agents and chemotherapy protocols based on prospective biological stratification of patients.Collaborative projects with international groups and institutions are crucial for this rare disease.", 
    "editor": [
      {
        "familyName": "Jaffe", 
        "givenName": "Norman", 
        "type": "Person"
      }, 
      {
        "familyName": "Bruland", 
        "givenName": "Oyvind S.", 
        "type": "Person"
      }, 
      {
        "familyName": "Bielack", 
        "givenName": "Stefan", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4419-0284-9_14", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4419-0283-2", 
        "978-1-4419-0284-9"
      ], 
      "name": "Pediatric and Adolescent Osteosarcoma", 
      "type": "Book"
    }, 
    "keywords": [
      "disease-free survival", 
      "adjuvant chemotherapy", 
      "nonmetastatic osteosarcoma", 
      "chemotherapy protocols", 
      "nonmetastatic high-grade osteosarcoma", 
      "bone tumor centers", 
      "Istituto Ortopedico Rizzoli", 
      "high-grade osteosarcoma", 
      "new active drugs", 
      "results of treatment", 
      "Rizzoli experience", 
      "amputation rate", 
      "neoadjuvant chemotherapy", 
      "resection rate", 
      "dose intensification", 
      "standard doses", 
      "grade osteosarcoma", 
      "cure rate", 
      "musculoskeletal tumors", 
      "study protocol", 
      "prechemotherapy era", 
      "rare disease", 
      "tumor center", 
      "active drug", 
      "chemotherapy", 
      "patients", 
      "osteosarcoma", 
      "extremities", 
      "biological stratification", 
      "disease", 
      "treatment", 
      "first experience", 
      "international group", 
      "prognosis", 
      "methotrexate", 
      "tumors", 
      "adriamycin", 
      "doses", 
      "cisplatin", 
      "Rizzoli", 
      "drugs", 
      "protocol", 
      "survival", 
      "rate", 
      "total", 
      "review", 
      "experience", 
      "group", 
      "aim", 
      "stratification", 
      "years", 
      "agents", 
      "center", 
      "Institute", 
      "regard", 
      "institutions", 
      "strategies", 
      "collaborative project", 
      "impact", 
      "results", 
      "era", 
      "introduction", 
      "future", 
      "different approaches", 
      "plateau", 
      "approach", 
      "intensification", 
      "project"
    ], 
    "name": "The Treatment of Nonmetastatic High Grade Osteosarcoma of the Extremity: Review of the Italian Rizzoli Experience. Impact on the Future", 
    "pagination": "275-287", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009972078"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4419-0284-9_14"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20213396"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4419-0284-9_14", 
      "https://app.dimensions.ai/details/publication/pub.1009972078"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-11-24T21:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/chapter/chapter_468.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4419-0284-9_14"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4419-0284-9_14'


 

This table displays all metadata directly associated to this object as RDF triples.

200 TRIPLES      22 PREDICATES      99 URIs      92 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4419-0284-9_14 schema:about N0c2b1f350a464820800ea058e35dbcf0
2 N1d1e2b718ade4c32b89bd3f6e8581c53
3 N3aeea7cc737a411abf4a8b74bab9d9ef
4 N70e8f690f5f549f0b544aa5646d83623
5 Na9904d8a54c64f2d91e14339173fc642
6 Ne65b2437e31c42b79ab02cf9e4006f5d
7 anzsrc-for:11
8 anzsrc-for:1112
9 schema:author N8cbe239113c74402b5256828e436567a
10 schema:datePublished 2009-08-12
11 schema:datePublishedReg 2009-08-12
12 schema:description The Bone Tumor Center of the “Istituto Ortopedico Rizzoli” was established in 1955 with the aim of studying and treating the musculoskeletal tumors. Between 1959 and 2006, 1245 patients with high grade nonmetastatic osteosarcoma of the extremity were treated at our Institute. Most of them were enrolled in study protocols.In the “prechemotherapy era”, the cure rate was 11%, with an amputation rate of 90%. Our first experience with adjuvant chemotherapy was in 1972. A total of 223 patients received adjuvant chemotherapy, with a disease-free survival (DFS) ranging from 45% to 53%, according to the chemotherapy protocol used. With the introduction of neoadjuvant chemotherapy, the resection rate increased and reached 94%, when high dose fosfamide was added to standard doses of methotrexate, cisplatin, and adriamycin.In the last few years, the results of treatment of nonmetastatic osteosarcoma of the extremity have reached a plateau (64% five-year DFS), and strategies of dose intensification are not able to improve the prognosis. Not only new active drugs, but also different approaches to the disease, are needed.In this regard, we are now investigating tumor microenvironment-targeted agents and chemotherapy protocols based on prospective biological stratification of patients.Collaborative projects with international groups and institutions are crucial for this rare disease.
13 schema:editor Nab012b4d84f848209e04bd9e93e44f3a
14 schema:genre chapter
15 schema:isAccessibleForFree false
16 schema:isPartOf Nf06a28622c2149c994adb4926b448b56
17 schema:keywords Institute
18 Istituto Ortopedico Rizzoli
19 Rizzoli
20 Rizzoli experience
21 active drug
22 adjuvant chemotherapy
23 adriamycin
24 agents
25 aim
26 amputation rate
27 approach
28 biological stratification
29 bone tumor centers
30 center
31 chemotherapy
32 chemotherapy protocols
33 cisplatin
34 collaborative project
35 cure rate
36 different approaches
37 disease
38 disease-free survival
39 dose intensification
40 doses
41 drugs
42 era
43 experience
44 extremities
45 first experience
46 future
47 grade osteosarcoma
48 group
49 high-grade osteosarcoma
50 impact
51 institutions
52 intensification
53 international group
54 introduction
55 methotrexate
56 musculoskeletal tumors
57 neoadjuvant chemotherapy
58 new active drugs
59 nonmetastatic high-grade osteosarcoma
60 nonmetastatic osteosarcoma
61 osteosarcoma
62 patients
63 plateau
64 prechemotherapy era
65 prognosis
66 project
67 protocol
68 rare disease
69 rate
70 regard
71 resection rate
72 results
73 results of treatment
74 review
75 standard doses
76 strategies
77 stratification
78 study protocol
79 survival
80 total
81 treatment
82 tumor center
83 tumors
84 years
85 schema:name The Treatment of Nonmetastatic High Grade Osteosarcoma of the Extremity: Review of the Italian Rizzoli Experience. Impact on the Future
86 schema:pagination 275-287
87 schema:productId N1f3cf73527c04c1589912ab196cc28ef
88 N3701d93060da4306ae4bb1d54756e281
89 N625d0180b2c344a1952c05cab70b637b
90 schema:publisher Na8941cb1737d4dd6a7cb6af92cc359f2
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009972078
92 https://doi.org/10.1007/978-1-4419-0284-9_14
93 schema:sdDatePublished 2022-11-24T21:19
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher Na7bfc7dd092c4f7587c733751f011352
96 schema:url https://doi.org/10.1007/978-1-4419-0284-9_14
97 sgo:license sg:explorer/license/
98 sgo:sdDataset chapters
99 rdf:type schema:Chapter
100 N0c2b1f350a464820800ea058e35dbcf0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Humans
102 rdf:type schema:DefinedTerm
103 N1479332c89d54bbcae4bdd13e7451dbd schema:familyName Bielack
104 schema:givenName Stefan
105 rdf:type schema:Person
106 N1d1e2b718ade4c32b89bd3f6e8581c53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Osteosarcoma
108 rdf:type schema:DefinedTerm
109 N1f3cf73527c04c1589912ab196cc28ef schema:name dimensions_id
110 schema:value pub.1009972078
111 rdf:type schema:PropertyValue
112 N3276d536f4024fd7a46c46eb9b850cfc rdf:first sg:person.01210215667.35
113 rdf:rest N9678c2241b174862931c83ffb5403833
114 N3701d93060da4306ae4bb1d54756e281 schema:name pubmed_id
115 schema:value 20213396
116 rdf:type schema:PropertyValue
117 N3aeea7cc737a411abf4a8b74bab9d9ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Bone Neoplasms
119 rdf:type schema:DefinedTerm
120 N4f2b0f4e91e849bf82e6ba597d27f86d schema:familyName Jaffe
121 schema:givenName Norman
122 rdf:type schema:Person
123 N59e09619ad424b67be9aa07e22dbff1f rdf:first Nfe110a7fca8d4b5caa7683e21e667179
124 rdf:rest N788c1045d8a74ec59d856dea84b9589e
125 N625d0180b2c344a1952c05cab70b637b schema:name doi
126 schema:value 10.1007/978-1-4419-0284-9_14
127 rdf:type schema:PropertyValue
128 N64d73eb96c2e4f419f5823f63f488e67 schema:familyName Bruland
129 schema:givenName Oyvind S.
130 rdf:type schema:Person
131 N70e8f690f5f549f0b544aa5646d83623 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Combined Modality Therapy
133 rdf:type schema:DefinedTerm
134 N788c1045d8a74ec59d856dea84b9589e rdf:first sg:person.0753274552.44
135 rdf:rest N8332a3ac02a34fff9d7aa4aae0bbd074
136 N8332a3ac02a34fff9d7aa4aae0bbd074 rdf:first sg:person.01275050611.54
137 rdf:rest rdf:nil
138 N8974b66b814a48b0b2e2425f600099ec rdf:first N64d73eb96c2e4f419f5823f63f488e67
139 rdf:rest Nd3e8d61992d549b2afe90e5e367bbcec
140 N8cbe239113c74402b5256828e436567a rdf:first sg:person.013005321532.44
141 rdf:rest N3276d536f4024fd7a46c46eb9b850cfc
142 N9678c2241b174862931c83ffb5403833 rdf:first sg:person.01324444267.96
143 rdf:rest Nba2ecc0ca2c143a8b76bf1202b35f158
144 Na7bfc7dd092c4f7587c733751f011352 schema:name Springer Nature - SN SciGraph project
145 rdf:type schema:Organization
146 Na8941cb1737d4dd6a7cb6af92cc359f2 schema:name Springer Nature
147 rdf:type schema:Organisation
148 Na9904d8a54c64f2d91e14339173fc642 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Extremities
150 rdf:type schema:DefinedTerm
151 Nab012b4d84f848209e04bd9e93e44f3a rdf:first N4f2b0f4e91e849bf82e6ba597d27f86d
152 rdf:rest N8974b66b814a48b0b2e2425f600099ec
153 Nba2ecc0ca2c143a8b76bf1202b35f158 rdf:first sg:person.01062073475.32
154 rdf:rest N59e09619ad424b67be9aa07e22dbff1f
155 Nd3e8d61992d549b2afe90e5e367bbcec rdf:first N1479332c89d54bbcae4bdd13e7451dbd
156 rdf:rest rdf:nil
157 Ne65b2437e31c42b79ab02cf9e4006f5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Prognosis
159 rdf:type schema:DefinedTerm
160 Nf06a28622c2149c994adb4926b448b56 schema:isbn 978-1-4419-0283-2
161 978-1-4419-0284-9
162 schema:name Pediatric and Adolescent Osteosarcoma
163 rdf:type schema:Book
164 Nfe110a7fca8d4b5caa7683e21e667179 schema:familyName Franco
165 schema:givenName Bertoni
166 rdf:type schema:Person
167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
168 schema:name Medical and Health Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
171 schema:name Oncology and Carcinogenesis
172 rdf:type schema:DefinedTerm
173 sg:person.01062073475.32 schema:familyName Mercuri
174 schema:givenName Mario
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062073475.32
176 rdf:type schema:Person
177 sg:person.01210215667.35 schema:familyName Palmerini
178 schema:givenName Emanuela
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210215667.35
180 rdf:type schema:Person
181 sg:person.01275050611.54 schema:familyName Bacci
182 schema:givenName Gaetano
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275050611.54
184 rdf:type schema:Person
185 sg:person.013005321532.44 schema:affiliation grid-institutes:grid.419038.7
186 schema:familyName Ferrari
187 schema:givenName Stefano
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013005321532.44
189 rdf:type schema:Person
190 sg:person.01324444267.96 schema:familyName Staals
191 schema:givenName Eric L.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324444267.96
193 rdf:type schema:Person
194 sg:person.0753274552.44 schema:familyName Picci
195 schema:givenName Piero
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753274552.44
197 rdf:type schema:Person
198 grid-institutes:grid.419038.7 schema:alternateName Sezione di Chemioterapia, dei Tumori dell’ Apparato Locomotore, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
199 schema:name Sezione di Chemioterapia, dei Tumori dell’ Apparato Locomotore, Istituto Ortopedico Rizzoli, via Pupilli 1, 40136, Bologna, Italy
200 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...